What happened
A JAMA Network Open analysis estimated that telehealth medication provision by US clinicians operating under shield laws rose from 24,460 in 2023 to 90,460 in 2025 among residents of 13 states with total abortion bans. Estimated out-of-state travel fell from 89,620 to 64,590 over the same period but remained substantial. A companion study of 13,548 Texas and Kansas patients found that telehealth and in-clinic medication-abortion pathways served different patient populations rather than functioning as simple substitutes.
Shield-law telehealth expanded faster than travel declined
The national analysis used the Guttmacher Institute's Monthly Abortion Provision Study to estimate clinician-provided abortions and cross-state travel. In 2025, shield-law telehealth accounted for most clinician-provided abortions to residents of several ban states, including Alabama, Arkansas, Louisiana, Mississippi, Oklahoma and Texas. Researchers estimated 90,460 telehealth provisions across all 13 ban states, compared with 64,590 residents travelling out of state for in-person care.
The increase in telehealth between 2024 and 2025 was larger than the reduction in travel. The authors say this could mean telehealth reached people who otherwise would not have obtained clinician-provided care, but the study cannot directly identify individual reasons. A mailed medication provision does not necessarily equal an abortion: some people may receive medicines more than once or not use them, while clinic travel may be undercounted when residence is not disclosed.
A companion study shows the pathways serve different groups
A separate cross-sectional analysis compared 12,823 telehealth patients with 725 in-clinic patients from Texas and Kansas over five months in 2024. Telehealth users tended to live farther from an abortion facility, accessed medication earlier in pregnancy and included higher proportions of Hispanic or Latine patients. These patterns suggest that distance and structural barriers help shape how people obtain care.
That comparison drew records from one telehealth service and one Kansas clinic, excluded minors because the clinic did not serve them, and covered medication abortion before 13 weeks rather than procedural care. Both papers describe access patterns within a changing legal environment; neither establishes a single preferred pathway, and legal availability can change quickly by jurisdiction.
Why it matters
Telehealth has become a major part of post-Dobbs abortion access, particularly for people living far from clinics, but tens of thousands still travel and require practical and financial support. Policy debates need to account for both pathways and the different populations they reach.
What to watch
Changes to shield laws and litigation, updated national estimates, patient-reported experiences, outcomes beyond medication provision and whether travel burdens shift across states. Readers should use current local legal and clinical information rather than relying on a news article for care access.
